AKT1 and hepatocellular carcinoma: MiRNA-199a/b-5p acts as a HCC-specific tumor suppressor, which inhibits Rho-associated protein kinase 1 (ROCK1) and modulates ROCK1/MLC and PI3K/AKT pathways, which are essential for HCC progression [100].